As of 2026-02-02, the Relative Valuation of Insmed Inc (INSM) is (94.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 156.87 USD, the upside of Insmed Inc based on Relative Valuation is -160.0%.
The range of the Relative Valuation is (92.03) - (95.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.6x - 17.9x | 17.0x |
| Forward P/E multiples | 14.7x - 17.1x | 16.9x |
| Fair Price | (92.03) - (95.14) | (94.09) |
| Upside | -158.7% - -160.7% | -160.0% |
| Date | P/E |
| 2026-01-30 | -28.26 |
| 2026-01-29 | -28.43 |
| 2026-01-28 | -28.08 |
| 2026-01-27 | -29.30 |
| 2026-01-26 | -28.77 |
| 2026-01-23 | -28.14 |
| 2026-01-22 | -28.89 |
| 2026-01-21 | -28.16 |
| 2026-01-20 | -29.46 |
| 2026-01-16 | -29.08 |
| 2026-01-15 | -28.69 |
| 2026-01-14 | -29.45 |
| 2026-01-13 | -29.49 |
| 2026-01-12 | -30.21 |
| 2026-01-09 | -31.70 |
| 2026-01-08 | -30.67 |
| 2026-01-07 | -31.71 |
| 2026-01-06 | -31.54 |
| 2026-01-05 | -31.56 |
| 2026-01-02 | -31.91 |
| 2025-12-31 | -31.35 |
| 2025-12-30 | -31.36 |
| 2025-12-29 | -31.77 |
| 2025-12-26 | -32.05 |
| 2025-12-24 | -31.96 |
| 2025-12-23 | -31.85 |
| 2025-12-22 | -31.66 |
| 2025-12-19 | -31.50 |
| 2025-12-18 | -30.00 |
| 2025-12-17 | -35.75 |
| 2025-12-16 | -36.15 |
| 2025-12-15 | -35.48 |
| 2025-12-12 | -35.49 |
| 2025-12-11 | -35.17 |
| 2025-12-10 | -34.20 |
| 2025-12-09 | -34.98 |
| 2025-12-08 | -35.41 |
| 2025-12-05 | -36.75 |
| 2025-12-04 | -36.94 |
| 2025-12-03 | -37.25 |
| 2025-12-02 | -37.22 |
| 2025-12-01 | -38.09 |
| 2025-11-28 | -37.43 |
| 2025-11-26 | -36.84 |
| 2025-11-25 | -37.66 |
| 2025-11-24 | -37.28 |
| 2025-11-21 | -35.81 |
| 2025-11-20 | -35.97 |
| 2025-11-19 | -36.67 |
| 2025-11-18 | -36.32 |